SCHEMBL8478562

SCHEMBL8478562

c1ccc(COCCCCCCCCCC2CO2)cc1

nearest known ligand 0.76

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
UGCG Q16739 7/20 0.47
GBA2 Q9HCG7 7/20 0.47
GBA1 P04062 6/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
EPHX2 P34913 2/20 0.44
TSHR P16473 2/20 0.44
TAAR1 Q96RJ0 1/20 0.42
LMNA P02545 1/20 0.42
LCT P09848 4/20 0.41
SI P14410 4/20 0.41
MGAM O43451 2/20 0.41
HRH4 Q9H3N8 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31549217 1.00 MEN1 (0.60) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL15516358 0.98 MEN1 (0.62) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL12903278 0.98 MEN1 (0.62) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL334794 0.98 MEN1 (0.62) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL334897 0.93 MEN1 (0.64) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL8483039 0.87 TSHR (0.58) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL334304 0.86 MEN1 (0.68) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL2186409 0.86 MEN1 (0.68) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL29606950 0.86 MEN1 (0.68) MEN1KMT2AUGCGGBA2GBA1
SCHEMBL2186406 0.86 MEN1 (0.68) MEN1KMT2AUGCGGBA2GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5871709-A TETRAAZACYCLODODECANE COMPOUNDS SUBSTITUTED WITH ALKYL CARBOXY COMPOUNDS FOR CARDIOVASCULAR DISORDERS AND BRAIN TUMORS SCHERING AKTIENGESELLSCHAFT (DE) 1999-02-16 US disclosed
EP-0485045-B1 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AG (DE) 1998-12-30 EP disclosed
US-5277895-A Nuclear magnetic resonance SCHERING AKTIENGESELLSCHAFT (DE) 1994-01-11 US disclosed
EP-0485045-A2 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AKTIENGESELLSCHAFT (DE) 1992-05-13 EP disclosed